Paris, France and Camberley, UK – 25 March 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 25 March 2022, the following Director purchased ordinary shares of €1/15 each in the Company (the “Ordinary Shares”):
http://novacyt.com/wp-content/uploads/2022/03/3.-Novacyt-Director-Dealings-DA-ENG.pdf